Advancing Public Health Through Vaccination: 2nd Edition

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines and Public Health".

Deadline for manuscript submissions: 30 September 2026 | Viewed by 1189

Special Issue Editors


E-Mail Website
Guest Editor
School of Medicine, Saint Camillus International University of Health Sciences, UniCamillus, 00131 Rome, Italy
Interests: vaccine hesitancy; psychological support
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Public Health Sciences and Paediatrics, University of Turin, 10126 Turin, Italy
Interests: vaccine hesitancy; public mental health
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Ministry of Health, 00144 Rome, Italy
Interests: vaccination policy; occupational health; mental health
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
Interests: prevention of infectious diseases; primary health care
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Global health is continuously changing; thus, we expect to face various challenges in the form of epidemics and pandemics. Vaccines play an important role in mitigating these challenges. The worldwide effort to vaccinate people has demonstrated how immunization can prevent serious consequences, save lives, and protect communities. The second edition of this Special Issue will investigate the evolving landscape of vaccination and explore solutions to achieve better vaccine uptake. We welcome original research, perspectives, and reviews that examine the latest advances in public health vaccination strategies, the role of vaccines in global health security, and ways to increase vaccination rates in vulnerable populations.

Dr. Maria Rosaria Gualano
Dr. Giuseppina Lo Moro
Dr. Gianluca Voglino
Dr. Erica De Vita
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epidemiology
  • vaccination strategies
  • vaccine hesitancy
  • health equity
  • vulnerable population

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 500 KB  
Article
Evaluation of the MenACWY Vaccination Catch-Up Campaign Among Adolescents in Madrid: Coverage, Trends, and Determinants
by Pablo Estrella-Porter, Amaya Sánchez-Gómez, María Dolores Lasheras Carbajo, Patricia Guillem Sáiz, Carmen Sáiz-Sánchez and Juan José Carreras
Vaccines 2026, 14(2), 152; https://doi.org/10.3390/vaccines14020152 - 4 Feb 2026
Viewed by 817
Abstract
Background: Invasive meningococcal disease (IMD) caused by Neisseria meningitidis remains a major public health concern due to its severity, lethality, and long-term sequelae. To address the rise in serogroups W and Y in Spain, the Community of Madrid implemented a catch-up campaign [...] Read more.
Background: Invasive meningococcal disease (IMD) caused by Neisseria meningitidis remains a major public health concern due to its severity, lethality, and long-term sequelae. To address the rise in serogroups W and Y in Spain, the Community of Madrid implemented a catch-up campaign in 2019–2021, targeting adolescents (ages 13–18) alongside routine tetravalent meningococcus vaccine (MenACWY) at age 12. This study evaluated MenACWY catch-up vaccination uptake in routine practice by describing vaccine coverage, temporal trends, and associated factors in adolescents born between 2001 and 2006. Methods: A population-based cross-sectional study was conducted using data from the Community of Madrid’s vaccination registry (SISPAL Vacunas). Vaccination coverage was calculated for adolescents with at least one recorded MenACWY dose from age 10 onwards. Temporal trends were analyzed by birth cohort and calendar time, and multivariable logistic regression models were used to identify factors associated with vaccination uptake. Results: Among 424,059 adolescents, overall vaccination coverage by December 2021 was 63.8%, ranging from 54.4% to 78.2% across birth cohorts. Coverage was highest in the 2006 cohort, likely due to co-administration with the tetanus and diphtheria (Td) booster. A slightly higher uptake was observed among females and adolescents with chronic conditions, while foreign-born adolescents consistently showed lower coverage. COVID-19 disruptions led to temporal variability, with sharp declines during lockdowns and partial recoveries thereafter, with persistent sociodemographic differences in uptake. Conclusions: By December 2021, coverage was incomplete, with marked variability across birth cohorts. Higher uptake was observed when vaccination was integrated into routine visits, while persistent sociodemographic disparities remained evident. These observational findings are consistent with the programmatic value of combined catch-up and routine strategies and the need for targeted actions to ensure equitable MenACWY coverage. Full article
(This article belongs to the Special Issue Advancing Public Health Through Vaccination: 2nd Edition)
Show Figures

Figure 1

Back to TopTop